Immune Checkpoint Drugs in Oncology: Analytical Tool – A Must-Have Handbook for Business Developers, BI/CI Operatives, and Clinical Developers
25 avr. 2024 10h26 HE
|
Research and Markets
Dublin, April 25, 2024 (GLOBE NEWSWIRE) -- The "Immune-checkpoint Drugs in Oncology: Analytical Tool" report has been added to ResearchAndMarkets.com's offering.Cancer cells sometimes find ways to...
Global Gallbladder Cancer Clinical Trials Review 2023: Region, Country (G7 & E7), Trial Status, Trial Phase, Sponsor Type and End Point Status
31 janv. 2024 06h46 HE
|
Research and Markets
Dublin, Jan. 31, 2024 (GLOBE NEWSWIRE) -- The "Gallbladder Cancer - Global Clinical Trials Review, 2023" clinical trials has been added to ResearchAndMarkets.com's offering.The clinical trial...
Apoptosis Assays Market Sees Robust Growth, Driven by Advances in Biomedical Research and Drug Development
05 janv. 2024 03h58 HE
|
Research and Markets
Dublin, Jan. 05, 2024 (GLOBE NEWSWIRE) -- The "Apoptosis Assays Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2018-2028" report has been added to ResearchAndMarkets.com's...
Pediatric Clinical Trials Market Forecasted Growth with New Innovations and Global Reach in 2023
20 déc. 2023 10h08 HE
|
Research and Markets
Dublin, Dec. 20, 2023 (GLOBE NEWSWIRE) -- The "Pediatric Clinical Trials Global Market Report 2023" report has been added to ResearchAndMarkets.com's offering. The pediatric clinical trials...
DNA Damage Response (DDR) Drugs in Oncology Analytical Tool 2022: The Must have Handbook for Any Business Developer, BI/CI Operative or Clinical Developer
26 juil. 2022 04h43 HE
|
Research and Markets
Dublin, July 26, 2022 (GLOBE NEWSWIRE) -- The "DNA Damage Response (DDR) Drugs in Oncology: Analytical Tool" report has been added to ResearchAndMarkets.com's offering. DNA Damage Response (DDR)...
World Immune-checkpoint Drugs in Oncology Analytical Handbook 2022
08 juin 2022 03h18 HE
|
Research and Markets
Dublin, June 08, 2022 (GLOBE NEWSWIRE) -- The "Immune-checkpoint Drugs in Oncology: Analytical Tool" report has been added to ResearchAndMarkets.com's offering. Immune-checkpoint Drugs in Oncology:...
2022 Oncolytic Virotherapies Analytical Tool: 85 Companies Who are Developing 150 Oncolytic Virus Drugs Where 113 are in Active Development in Cancer Across 40 Different Targets
11 mai 2022 07h03 HE
|
Research and Markets
Dublin, May 11, 2022 (GLOBE NEWSWIRE) -- The "Oncolytic Virotherapies: Analytical Tool" report has been added to ResearchAndMarkets.com's offering.Oncolytic Virotherapies: Analytical Tool is the...